昆明做打胎到底要多少钱昆明做人流去哪家医院合适,昆明怀孕四十七天打胎多少钱,昆明做人流到底哪个医院好,昆明流产那个医院好啊,昆明那就医院做人流比较好,昆明大流产医院,昆明妇科医院打胎的费用

Hello! And welcome to Movie...Pass?MoviePass, the ticket subscription company, is buying Moviefone, the 29-year old movie directory service.A lot has changed since Moviefone first started. It's hard to imagine now, but people used to call a number for movie times. Moviefone became so popular that its famous "Welcome to Moviefone" greeting was parodied in a famous "Seinfeld" episode.Moviefone still has a website and app, but it retired the 777-FILM phone service in 2014. (Seinfeld's Kramer must be pleased. "Why don't you just tell me the name of the movie you've selected?")AOL, now part of Verizon, bought Moviefone in 1999 for 8 million. But MoviePass isn't spending nearly as much to get Moviefone. MoviePass majority owner Helios and Matheson Analytics will pay Verizon only about million for Moviefone -- million in cash and a mix of HMNY stock and warrants worth about million, according to a Securities and Exchange filing Thursday.According to Business Insider, MoviePass has also welcomed back service to a handful of AMC theaters in big cities, including San Diego.The service removed 10 of AMC's busiest locations from its app in January to take a "hard position" against theater chain. MoviePass has been seeking a a portion of concessions sales.WHY MOVIEFONE?So why does MoviePass want Moviefone? MoviePass CEO Mitch Lowe told CNNMoney it wanted access to Moviefone's film and TV show content."Our subscribers want to connect with Hollywood and hear more about what's going on in the film industry," Lowe said. "They'd like to have MoviePass recommend movies to them and Moviefone is iconic."Lowe, a co-founder of Netflix and former president of DVD rental kiosk service Redbox, added that he hopes the acquisition will be a "great funnel to attract new members" to MoviePass, which currently has more than 2 million subscribers.Ted Farnsworth, CEO of Helios and Matheson Analytics, added that the marriage of MoviePass and Moviefone will hopefully lead to more advertising revenue."MoviePass is growing at warp speed. Put it and Moviefone together and it gives us more advertising opportunities," Farnsworth said in an interview with CNNMoney. "This is a great strategic move for us."MoviePass arguably needs more ad sales to convince skeptical investors that its business model of buying tickets from theaters and then offering them to subscribers at a discount through monthly and annual subscription plans is viable for the long haul. MoviePass lets people see a movie a day for .95 a month -- it recently cut its price from .95.Shares of Helio and Matheson Analytics have plunged nearly 55% this year. Investors are worried that MoviePass won't be profitable anytime soon.THREAT OF COMPETITIONPart of the problem? We live in an era of so-called peak TV. Netflix, other streaming services and big cable TV networks are churning out more and more quality shows that eat into the time people have to go to movies.Investors also worry that the big chains that MoviePass currently buys tickets from -- AMC, Regal and Cinemark -- may eventually look to cut out MoviePass and launch their own subscription services or other lower-priced deals.Regal, which is now owned by UK-based Cineworld, has experimented with charging more for tickets during peak movie times and less at times when attendance tends to be lighter. Think of it as Uber-style surge pricing, but for movies.And Cinemark unveiled Movie Club, a monthly plan that lets people buy a movie ticket a month for a discounted price of .99, last year.That deal obviously isn't as good as the one a day plan offered by MoviePass. But Cinemark will also allow Movie Club members to roll over unused tickets every month, bring friends at the lower price and offers bargains on concession stand items.Lowe isn't too concerned about competition though. He said he's convinced that MoviePass will continue to work closely with the big chains -- even if Wall Street is nervous."We have to prove we are a driving force in getting more people into theaters. We have to try and put our money where our mouth is," he said. 4118

GrubHub released its list of top trending foods of 2020, and according to its data, the spicy chicken sandwich was the top trending food item of the year.GrubHub analyzed orders from its 30 million customers in 2020 to unveil the list.According to GrubHub, spicy chicken sandwiches saw a more than 300% increase in popularity in 2020.Here is the top trending foods in 2020:Spicy chicken sandwich: 318% more popularChicken burrito bowl: 299% more popularChicken wings: 287% more popularWaffle fries: 221% more popularCold brew coffee: 206% more popularSteak quesadilla: 164% more popularIced latte: 157% more popularFish and chips: 146% more popularStrawberry shake: 131% more popularRoast beef sandwich: 126% more popularGrubHub also said that French fries were the top trending side dish of 2020, acai bowls were the top breakfast item of the year, strawberry cheesecake took the nod for top dessert.As for the largest single order, someone in 2020 ordered 300 bean burritos at once.For more info, click here. 1018

From the International Space Station: I voted today— Kate Rubins pic.twitter.com/DRdjwSzXwy— NASA Astronauts (@NASA_Astronauts) October 22, 2020 152

Governor Whitmer of Michigan has done a terrible job. She locked down her state for everyone, except her husband’s boating activities. The Federal Government provided tremendous help to the Great People of Michigan. My Justice Department and Federal Law Enforcement announced...— Donald J. Trump (@realDonaldTrump) October 9, 2020 344

Genetic testing company 23andMe has been given federal approval to sell at-home kits that test for three breast cancer gene mutations.This will be the first direct-to-consumer DNA test for these particular breast cancer gene mutations, the Food and Drug Administration said on Tuesday.A spokeswoman for 23andMe said the test for the three BRCA1/BRCA2 breast cancer gene mutations will be added "in the coming weeks" to the broader Health + Ancestry services, with no increase to the existing 9 cost.The test can only detect three out of more than 1,000 known BRCA mutations, according to the FDA. The BRCA1/BRCA2 hereditary mutations occur in about 2% of Ashkenazi Jewish women, but rarely occur in anyone else, the agency said in a press release."The test also does not provide information on a person's overall risk of developing any type of cancer," the FDA added.23sandMe already tests for genetic health risks for diseases like Parkinson's and Alzheimer's, along with wellness reports for things like lactose intolerance and saturated fat, and ancestral composition including Neanderthal ancestry.In 2013, the FDA ordered the company to stop sales of its home-testing kits, saying the Alphabet-backed company had failed to prove the validity of its product.Related: 23andMe gets funding for drug developmentAnne Wojcicki, who founded the company in 2006, called the FDA shutdown a "transformative moment" that prompted 23andMe to branch into drug development."Thank you to the FDA for hard work and progress on innovation," she tweeted on Tuesday.In 2015, 23andMe received approval from the FDA to test customers for whether they are carriers of certain disease-carrying genes that could be passed on to their children. In early 2017, the company received approval to issue genetic health risk reports.In September of last year, the company said it received 0 million in funding from Sequoia Capital to develop drugs based on user DNA.The-CNN-Wire? & ? 2018 Cable News Network, Inc., a Time Warner Company. All rights reserved. 2050